HCK Capital sets a new standard in green living
Today, green-certified buildings are no longer a luxury. They are a practical solution for a more sustainable lifestyle and a healthier environment.
Therefore, property developers are increasingly motivated to have their projects green certified to better express their commitment for a greener, more sustainable world.
Locally, GreenRE stands at the forefront of green building certification and having its seal of recognition is the gold standard for any developer looking to make a green statement.
For starters, a GreenRE certified development excels in energy and water efficiency.
It is also a key requirement to promote healthier indoor environments while embracing environmentally responsible construction methods.
These green buildings not only help reduce ecological impact but also offer long-term savings for both property owners and tenants.
Choosing to live or work in a GreenRE-certified property means lower utility expenses, cleaner air indoors, and the reassurance of making a meaningful, forward-thinking decision.
It is a choice that delivers long-term value, both financially and environmentally.
Beyond cost savings, green buildings are designed with well-being in mind. Elements such as natural light, good ventilation, and climate-responsive design contribute to healthier, more comfortable living and working environments. These features improve everyday experiences while reducing the strain on natural resources.
Now that all these winning features are being mentioned, it comes as no surprise that award-winning property developer HCK Capital has a number of its projects with the GreenRE certification.
Projects like e.Sentral SmartCity and edumetro have earned GreenRE certification for meeting high sustainability standards, reflecting HCK's dedication to creating smart, future-oriented communities.
For HCK, sustainability isn't an added bonus. It is a core principle. By integrating green practices into our developments, HCK aims to build not just for today, but for a more sustainable tomorrow. —June 10, 2025
Main image: Elemental Green
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Star
3 hours ago
- The Star
New ESG association to drive sustainability practices
SEAM vice-president Alex Yeoh (left) and founding president Liang Yit Wen KUALA LUMPUR: The Sustainability & ESG Association Malaysia (SEAM) had its soft launch today with the aim to drive meaningful environmental, social, and governance (ESG) adoption through real-world implementation. According to the association's statement, its cornerstone is the IDEA-C Framework – a structured approach designed to help corporates identify ESG opportunities, diagnose gaps, engineer solutions, activate change, and communicate measurable impact. "SEAM fills a critical market gap by connecting ESG-certified professionals and solution providers with businesses seeking verified, scalable sustainability practices," it said. SEAM's membership is open to ESG-certified professionals, consultants, implementors, compliant corporates, and relevant institutional alliances. The association will also work closely with stakeholders such as regulators, certification bodies, and capital market players. "We provide a trusted, neutral platform that brings both sides together, helping businesses take action confidently, and enabling solution providers to scale their impact. "Our aim is to turn ESG from ambition into execution, and from pledges into measurable value," said SEAM founding president Liang Yit Wen.
Malaysian Reserve
21 hours ago
- Malaysian Reserve
Nelson-Jameson Distribution Center Earns 100% Score On Its First Safe Quality Food Audit
The Jerome, Idaho facility is the latest distribution center location to achieve the SQF Institute's top global food safety and quality certification MARSHFIELD, Wis, July 23, 2025 /PRNewswire/ — Nelson-Jameson, a leading distributor in the food processing industry, has announced that its Jerome, Idaho strategic distribution center has earned a 100% score in its first Safe Quality Food (SQF) audit. An SQF-certified site indicates a company's commitment to providing quality products that are safely received, handled, stored, and delivered. A 100% score represents the highest level of food safety and food quality. The 100% perfect rating comes in the first audit of the Jerome strategic distribution center, which opened in 2024. This perfect score is the fourth straight for Nelson-Jameson in the past year across all distribution centers. 'Our Jerome distribution center earning a perfect SQF certification illustrates that our dedication to food safety is a throughline in everything we do in every facility we have,' says Mike Rindy, President of Nelson-Jameson. 'We take pride in our distribution center having achieved this perfect score during the audits, and in our team's commitment to maintaining food and worker safety every day.' The SQF program motto is: 'Say what you do, do what you say.' SQF has a code for each company to follow, and each individual company writes its policies and procedures based on the code. Maintaining these procedures is a continuous process, as documentation must be reviewed, monitored, verified, and validated throughout the year. The Eagle Certification Group, an independent certification company authorized by the SQF Institute, conducts the audits in adherence to the globally acknowledged industry standards set by SQF. Learn more about the SQF program at Nelson-Jameson is a fourth-generation, family-owned distributor to the food processing industry. From the company's roots in dairy production supplies, it has expanded to offer a broad range of food processing products and services that help food and beverage organizations operate efficiently with the highest quality, food safety, and compliance standards. The company represents more than 1,000 vendors, distributes more than 79,000 curated products, and employs more than 300 people nationwide. The food processing industry leader also operates NEXT Logistics, a transportation arm that provides delivery services from its Wisconsin, California, Idaho, Pennsylvania, and Texas strategic distribution centers. Since 1947, Nelson-Jameson has supported food, beverage, and dairy processors with innovative products and a comprehensive set of solutions that keep pace with changing consumer tastes, manufacturing processes, and distribution channels. The company values delivering the exceptional for its customers by leading with the guiding principles of kindness and mutual respect. Nelson-Jameson is a supplier of choice for customers in all 50 states and international markets. For more information, please visit
Focus Malaysia
a day ago
- Focus Malaysia
Southeast Asia pharma market set to outgrow global average
SOUTHASIA Asia (SEA) presents a substantial future prospect for the pharmaceutical market. Its projected growth rate significantly outpaces the global average and other major established markets. As of calendar year 2024 (CY24), global total market size for pharmaceuticals is estimated at USD1.5 tri. In comparison, SEA's total market size is estimated at USD27 bil. The significant growth for SEA indicates that ASEAN is a prime growth engine for the global pharmaceutical industry. This makes it an attractive destination for investment and market expansion. The Philippines and Malaysia show steady growth in a biosimilar export potential, reaching USD 111 mil and USD 70 mil respectively by 2027. Malaysia's growth, though robust, is relatively smaller in absolute terms compared to Thailand, Vietnam, and Indonesia. However, companies like Duopharma and Pharmaniaga are actively developing Halal-certified biosimilars. Overall, biosimilars is an untapped potential due to increasing healthcare demands and cost pressure. 'We believe that investing in local manufacturing of biosimilars can open avenues for SEA countries to export,' said MBSB Research. Countries that prioritise and invest in local biosimilar production are likely to become stronger exporters in this field. This aligns with the broader trends of high pharmaceutical market growth in SEA driven by demographics, NCDs, and the increasing sophistication of healthcare systems, all of which necessitate tailored and creative market strategies. Malaysia's pharmaceutical sector boasts a strong and strategically recognized local manufacturing base that significantly contributes to medicine security, especially for generics and essential medicines. While Malaysia demonstrates capabilities in exporting to highly regulated markets like the USA, it remains heavily reliant on imports for patented drugs, biologics, vaccines, and key APIs. The main challenge for Malaysia lies in bridging this gap by further boosting local R&D, attracting more sophisticated manufacturing capabilities, and strengthening its position in the global pharmaceutical value chain beyond just generics. 79% of total volume of generic medicines and 47% of items listed in National Essential Medicines List (NEML) are locally produced. However, most drugs, notably patented medicaments, immunoglobulins, human vaccines and insulins, are still dependent on imports. Malaysia consistently shows widening trade deficit underscores Malaysia's high reliance on imported pharmaceuticals. While local production is strong in generics, the country still depends heavily on foreign sources for innovative, patented, and specialised medicines. This reinforces the government's strategic focus on local manufacturing and technology transfer to enhance medicine security and reduce import dependency in the long run. The overall trend in the regional and local pharmaceutical market suggests that both domestic and foreign investors will see growing opportunities in Malaysia. The 51% FDI / 49% DDI ratio suggests a healthy balance between local commitment, and global capital and expertise. FDI indicates that Malaysia is highly attractive to foreign pharmaceutical companies, bringing in capital, technology, and global best practices, while DDI signifies robust local entrepreneurship and investment from Malaysian companies, demonstrating confidence in the domestic market and capabilities. We opine that the untapped drug manufacturing ecosystem will continue to follow the megatrend of new innovative drugs – including biologics, biosimilars and cell & gene therapy drugs – and open more opportunities for Malaysia to be a major healthcare hub in the region. While direct pharmaceutical exports from Malaysia to the US might face immediate headwinds from tariffs, the broader impact on Malaysia's healthcare subsector could come from indirect effects on global pharmaceutical supply chains and procurement costs. This would affect the affordability and availability of medicines within Malaysia for all citizens and healthcare providers. The Malaysian government and industry players are already responding by prioritizing supply chain diversification and exploring domestic production enhancements to mitigate these risks. Meanwhile, we believe a multi-pronged approach involving government action, industry adaptation, and consumer awareness will be crucial. Overall, we maintain positive on the healthcare sector. The pharmaceutical market is fundamentally driven by robust demographic trends, which naturally increases the demand for healthcare services and medicines. —July 23, 2025 Main image: Daily Sabah
